Melipharm Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Melipharm General Information
Description
Developer of sterile medical devices intended for the treatment of acute and chronic wounds. The company's sterile medical devices are a natural product that come from the selection of honey essences whose anti-bacterial and healing properties have been validated by the researchers in the laboratory, enabling doctors to treat acute and chronic wounds based on selected monofloral honey.
Contact Information
Website
www.melipharm.comCorporate Office
- 1 avenue d'Ester
- Cedex 3
- 87069 Limoges
- France
Corporate Office
- 1 avenue d'Ester
- Cedex 3
- 87069 Limoges
- France
Melipharm Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Secondary Transaction - Private | 01-Aug-2023 | 00000 | Completed | Generating Revenue | ||
| 3. Angel (individual) | 01-Oct-2014 | 00000 | Completed | Generating Revenue | ||
| 2. Angel (individual) | 24-Jan-2012 | $156K | $296K | 00000 | Completed | Startup |
| 1. Angel (individual) | 27-Jul-2009 | $140K | $140K | 00000 | Completed | Startup |
Melipharm Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 0,000 | 000.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.00 | |
| Ordinary | 0,000 | 000.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 |
Melipharm Patents
Melipharm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3142687-A1 | Antimicrobial composition comprising a carbohydrate, glucose oxydase and zinc oxide | Inactive | 14-May-2014 | 0000000000 | 0 |
| FR-3020948-B1 | Antimicrobial composition | Active | 14-May-2014 | 0000000000 | |
| US-20170072024-A1 | Antimicrobial composition comprising a carbohydrate, glucose oxidase and zinc oxide | Inactive | 14-May-2014 | 0000000000 | |
| FR-3020948-A1 | Antimicrobial composition | Active | 14-May-2014 | 0000000000 | 0 |
| EP-4032542-A1 | Antimicrobial composition comprising a carbohydrate, glucose oxidase and zinc oxide | Inactive | 14-May-2014 | A61K38/443 | 00 |
Melipharm Executive Team (2)
| Name | Title | Board Seat |
|---|---|---|
| Celine Archer | Co-Founder & President |
Melipharm Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Melipharm Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Limousin Business Angels | Angel Group | Minority | 000 0000 | 000000 0 |
Melipharm FAQs
-
When was Melipharm founded?
Melipharm was founded in 2009.
-
Who is the founder of Melipharm?
Celine Archer and Fabien Quero are the founders of Melipharm.
-
Where is Melipharm headquartered?
Melipharm is headquartered in Limoges, France.
-
What is the size of Melipharm?
Melipharm has 7 total employees.
-
What industry is Melipharm in?
Melipharm’s primary industry is Other Devices and Supplies.
-
Is Melipharm a private or public company?
Melipharm is a Private company.
-
What is Melipharm’s current revenue?
The current revenue for Melipharm is 00000.
-
How much funding has Melipharm raised over time?
Melipharm has raised $296K.
-
Who are Melipharm’s investors?
Limousin Business Angels has invested in Melipharm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
